A deeper understanding of CHI3L1’s influence on glial cell activity, amyloid deposition, and the neuroinflammatory environment could lead to more targeted therapeutic strategies aimed at slowing AD progression or preventing its symptoms. Here, CHI3L1 is linked to Alzheimer disease.